Protection against influenza virus challenge by topical application of influenza DNA vaccine (Q38492551)

3 September 2017

Protection against influenza virus challenge by topical application of influenza DNA vaccine (English)

1 reference

3 September 2017

Watabe S

1

1 reference

3 September 2017

Xin KQ

2

1 reference

3 September 2017

Ihata A

3

1 reference

3 September 2017

Liu LJ

4

1 reference

3 September 2017

Honsho A

5

1 reference

3 September 2017

Aoki I

6

1 reference

3 September 2017

Hamajima K

7

1 reference

3 September 2017

Wahren B

8

1 reference

3 September 2017

Okuda K

9

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

3 September 2017

1 reference

3 September 2017

19

1 reference

3 September 2017

31

1 reference

3 September 2017

4434-4444

1 reference

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Structural effects of the C2-methylhypoxanthine:cytosine base pair in B-DNA: A combined NMR and X-ray diffraction study of d(CGC[m2I]AATTCGCG).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Protection of mice against a lethal influenza virus challenge after immunization with yeast-derived secreted influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Protection against mycoplasma infection using expression-library immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Cytotoxic T lymphocyte control of acute lymphocytic choriomeningitis virus infection: interferon gamma, but not tumour necrosis factor alpha, displays antiviral activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-gamma antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Antigenic structure of myoglobin: the complete immunochemical anatomy of a protein and conclusions relating to antigenic structures of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Immunization via hair follicles by topical application of naked DNA to normal skin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Individual cells simultaneously produce both IL-4 and IL-6 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Enhancement of immune response to intranasal influenza HA vaccine by microparticle resin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Vaccination onto bare skin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

Potential DNA vaccine integration into host cell genome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900194-3

7 January 2021

10.1016/S0264-410X(01)00194-3

Identifiers

DOI

1 reference

3 September 2017

1 reference